Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
This study is ongoing, but not recruiting participants.
Study NCT00280215 Information provided by Mayo Clinic
First Received: January 19, 2006 Last Updated: July 31, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperoxaluria
Additional conditions recognized in this trial
Hyperoxaluria, Primary
More general conditions related to this trial
Carbohydrate Metabolism, Inborn Errors
Genetic Diseases, Inborn
Kidney Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Urologic Diseases
Interventions listed in this trial
ARB /Angiotensin Receptor Blocker
Placebo
Additional drug interventions recognized in this trial
Angiotensin-Converting Enzyme Inhibitors
Enzyme Inhibitors
Lisinopril
More general drug interventions related to this trial
Antihypertensive Agents
Cardiotonic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
